Drug · DIN 02297124
STARNOC
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since November 11, 2021.
- Drug Identification Number (DIN)
- 02297124
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Zaleplon N05CF03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ZALEPLON | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 1, 2010: NOC 11771New Drug Submission (NDS) · Manufacturer name change
- July 18, 2007: NOC 8916New Drug Submission (NDS) · Manufacturer name change
Other DINs named STARNOC
- DIN 02242219 · Cancelled Post Market
- DIN 02242220 · Cancelled Post Market
- DIN 02297132 · Cancelled Pre Market